Overview

Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)

Status:
Unknown status

Trial end date:
2019-12-01

Target enrollment:

Participant gender:

Summary

This study evaluates in a group of people with DM 1 the influence in parameters of oxidative stress of the treatments with the different current analogs of insulin

Phase:

Phase 4

Details

Lead Sponsor:

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Treatments:

Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin Glargine
Insulin glulisine
Insulin Lispro
Insulin, Globin Zinc
Insulin, Long-Acting